129 related articles for article (PubMed ID: 21246897)
1. [Rivastigmine in the treatment of dementia: from the symptomatic effect to neuroprotection].
Damulin IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):76-82. PubMed ID: 21246897
[No Abstract] [Full Text] [Related]
2. Dementia medications in palliative care #174.
Morrison LJ; Liao S
J Palliat Med; 2008 May; 11(4):634-5. PubMed ID: 18454618
[No Abstract] [Full Text] [Related]
3. Dementia treatment update.
Buffum MD; Buffum JC
Geriatr Nurs; 2005; 26(2):74-8. PubMed ID: 15824717
[No Abstract] [Full Text] [Related]
4. Rivastigmine for dementia associated with Parkinson's disease.
Harada CN; Shega JW; Sachs GA
N Engl J Med; 2005 Mar; 352(13):1387; author reply 1387. PubMed ID: 15800242
[No Abstract] [Full Text] [Related]
5. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.
Devos D; Moreau C; Maltête D; Lefaucheur R; Kreisler A; Eusebio A; Defer G; Ouk T; Azulay JP; Krystkowiak P; Witjas T; Delliaux M; Destée A; Duhamel A; Bordet R; Defebvre L; Dujardin K
J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):668-74. PubMed ID: 24218528
[TBL] [Abstract][Full Text] [Related]
7. Understanding changes in cholinergic function: implications for treating dementia.
J Clin Psychiatry; 2002 Mar; 63(3):259-69. PubMed ID: 11926730
[No Abstract] [Full Text] [Related]
8. Rivastigmine: in Parkinson's disease dementia.
Siddiqui MA; Wagstaff AJ
CNS Drugs; 2006; 20(9):739-47; discussion 748-50. PubMed ID: 16953649
[TBL] [Abstract][Full Text] [Related]
9. Rivastigmine for Alzheimer's disease.
Drug Ther Bull; 2000 Feb; 38(2):15-6. PubMed ID: 10829350
[TBL] [Abstract][Full Text] [Related]
10. [Rivastigmine against dementia in Parkinson disease?].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
[No Abstract] [Full Text] [Related]
11. [Effect of AChE and BuChE inhibition by rivastigmin in a group of old-old elderly patients with cerebrovascular impairment (SIVD type)].
Servello A; Andreozzi P; Bechini F; De Angelis R; Pontecorvo ML; Vulcano A; Cerra E; Vigliotta MT; Artini M; Selan L; Ettorre E
Minerva Med; 2014 Apr; 105(2):167-74. PubMed ID: 24727881
[TBL] [Abstract][Full Text] [Related]
12. Rivastigmine in Parkinson's disease dementia: profile report.
Siddiqui MA; Wagstaff AJ
Drugs Aging; 2007; 24(3):255-9. PubMed ID: 17362052
[No Abstract] [Full Text] [Related]
13. Frontotemporal dementia and pharmacologic interventions.
Kaye ED; Petrovic-Poljak A; Verhoeff NP; Freedman M
J Neuropsychiatry Clin Neurosci; 2010; 22(1):19-29. PubMed ID: 20160206
[TBL] [Abstract][Full Text] [Related]
14. Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Noble JM; Hauser WA
Neurology; 2007 May; 68(20):1749; author reply 1750. PubMed ID: 17502565
[No Abstract] [Full Text] [Related]
15. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Moerkens RM; Dhondt AD
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
[No Abstract] [Full Text] [Related]
16. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
17. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
Alwahhabi FK
J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444
[TBL] [Abstract][Full Text] [Related]
18. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Mol JA
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
[No Abstract] [Full Text] [Related]
19. The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.
Bullock R
Int J Clin Pract; 2002 Apr; 56(3):206-14. PubMed ID: 12018828
[TBL] [Abstract][Full Text] [Related]
20. Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.
Fogelson N; Kogan E; Korczyn AD; Giladi N; Shabtai H; Neufeld MY
Acta Neurol Scand; 2003 Apr; 107(4):252-5. PubMed ID: 12675697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
